Baird analyst Michael Halloran downgraded Evoqua Water (AQUA) to Neutral from Outperform with an unchanged price target of $49 after the company entered into a definitive agreement under which Xylem (XYL) will acquire Evoqua in an all-stock transaction that reflects an implied enterprise value of approximately $7.5B.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AQUA: